A2T (p.Ala2Thr) variant of NF1 (Neurofibromin)
A2T (p.Ala2Thr) in NF1 (Neurofibromin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Neurofibromatosis, type 1. The available variant effect predictions contribute to a CATVariant prioritization score of 0.32 / 1. The record also includes published literature and structural context.
A2T (p.Ala2Thr) variant details
- p.Ala2Thr
- rs2143144232
- ClinGen CA398979159
- ClinVar RCV003599133
- Ensembl rs2143144232
- Uncertain significance
- Neurofibromatosis, type 1
- Missense
- Variant Prioritization Score for Impact Estimate 0.323
- AlphaMissense 0.32
- MetaLR 0.07
- MetaSVM -1.11
- PolyPhen-2 1.00
- SIFT 0.02
- MutPred 0.14
- ClinVar: Uncertain significance (Neurofibromatosis, type 1)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Structural context available
- Cited in: Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. (PMID 15604628)
- Cited in: Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors. (PMID 17636453)